Tag: Pfizer
Pfizer: Jefferies raises its advice on the stock
(CercleFinance.com) – Jefferies raises its opinion on the stock by switching to buy (versus hold) and raising its price target to $39 (instead of $38) following the new targets for…
Pfizer expected to decline after disappointing sales of its anti-Covid products
(AOF) – Pfizer is expected to fall in pre-market on Wall Street after reducing its revenue forecasts for the whole year by 13% on Friday and announcing a savings plan…
Pfizer: Will present data to ESMO
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
End of the vaccine boom: Biontech has to act after Pfizer’s forecast correction
End of the vaccine boom Biontech has to act after Pfizer’s forecast correction October 16, 2023, 3:58 p.m With its corona vaccine, Pfizer and Biontech are making a significant contribution…
AstraZeneca: Alexion completes transaction with Pfizer
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer: Commission authorization for alopecia areata
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer: the new Covid vaccine approved by the EU
(CercleFinance.com) – The European Commission has announced that it has authorized the adapted vaccine against COVID-19, Comirnaty XBB.1.5, developed by BioNTech-Pfizer. This vaccine marks another important step in the fight…
Covid-19: the European regulator approves a new vaccine adapted from Pfizer
The European Medicines Agency (EMA) on Wednesday approved an adapted version of the Covid vaccine from Pfizer and BioNTech to counter infection with a widespread subvariant of the virus as…
Pfizer: EU green light to market Abrysvo
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Pfizer: New data on anti-coagulants
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Pfizer: EU green light to market Abrysvo
(CercleFinance.com) – Pfizer announced that the European Commission (EC) has granted marketing authorization for Abrysvo™, its bivalent respiratory syncytial virus (RSV) vaccine intended to help protect infants through maternal vaccination…
Pfizer: new data on anti-coagulants
(CercleFinance.com) – The Bristol Myers Squibb – Pfizer alliance today presented the results of a retrospective real-world data study showing that switching from Eliquis ® (apixaban) to rivaroxaban in patients…